丹参注射液联合泮托拉唑钠治疗急性胰腺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R576

基金项目:


Clinical Study on Danshen Injection Combined with Pantoprazole Sodium for Acute Pancreatitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察丹参注射液联合泮托拉唑钠治疗急性胰腺炎的疗效及对其血清因子的影响。方法:选取98 例急性胰腺炎患者作为研究对象,按计算机分组法分为观察组及对照组各49 例。对照组接受泮托拉唑钠治疗,观察组在对照组基础上联合丹参注射液治疗,2 组均持续治疗14 d。比较2 组治疗前后改良CT 严重指数(MCTSI)、中医证候积分、血清指标[肿瘤坏死因子-α (TNF-α)、C-反应蛋白(CRP)、白细胞介素-6 (IL-6)] 值的变化,治疗结束1 个月后随访观察2 组并发症发生率及生存率。结果:治疗后,2 组MCTSI 评分均较治疗前下降,观察组MCTSI 评分低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组中医证候积分均较治疗前下降,观察组中医证候积分低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组TNF-α、IL-6、CRP 水平均较治疗前下降,观察组上述3 项水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,观察组并发症发生率为4.08%,对照组为6.12%,差异无统计学意义(P>0.05);观察组生存率为97.96%,对照组为95.92%,差异无统计学意义(P>0.05)。结论:丹参注射液联合泮托拉唑钠治疗急性胰腺炎的疗效显著,可有效改善其临床症状及体征,有效控制血清炎性因子水平,降低不良反应发生率,提高生存率。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Danshen injection combined with pantoprazole sodium for acute pancreatitis and its effect on serum factors. Methods:A total of 98 cases of patients with acute pancreatitis were selected and divided into the observation group and the control group according to the computer grouping method, with 49 cases in each group. The control group was treated with pantoprazole sodium,and the observation group was additionally treated with Danshen injection based on the treatment of the control group. Both groups were treated for 14 days. The changes in Modified CT Severity Index(MCTSI),Chinese medicine syndrome scores,and serum indexes including tumor necrosis factor- α(TNF- α),C- reactive protein(CRP) and interleukin- 6(IL- 6) before and after treatment in the two groups were compared. The incidence of complications and survival rates in the two groups were followed up and observed one month after treatment. Results:After treatment,MCTSI scores in the two groups were decreased when compared with those before treatment, and the MCTSI score in the observation group was lower than that in the control group, differences being significant(P<0.05). After treatment, Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment,and the Chinese medicine syndrome score in the observation group was lower than that in the control group,differences being significant(P<0.05). After treatment,the levels of TNF-α,IL-6 and CRP in the two groups were decreased when compared with those before treatment, and the above three levels in the observation group were lower than those in the control group,differences being significant(P< 0.05). After treatment,the incidence of complications was 4.08% in the observation group and 6.12% in the control group,there being no significance in the difference(P>0.05). The survival rate was 97.96% in the observation group and 95.92% in the control group,there being no significance in the difference(P> 0.05). Conclusion:The therapy of Danshen injection combined with pantoprazole sodium for patients with acute pancreatitis has a significant effect,and can effectively improve their clinical symptoms and signs, effectively control the levels of serum inflammatory factors, reduce the incidence of adverse reactions, and increase the survival rate.

    参考文献
    相似文献
    引证文献
引用本文

张继盛,刘兵,王理富.丹参注射液联合泮托拉唑钠治疗急性胰腺炎临床研究[J].新中医,2022,54(17):97-100

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-09-06
  • 出版日期:
文章二维码